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A B S T R A C T
The importance of incorporating Natural Language Processing (NLP) methods in clinical informatics research has
been increasingly recognized over the past years, and has led to transformative advances.
Typically, clinical NLP systems are developed and evaluated on word, sentence, or document level annota-
tions that model specific attributes and features, such as document content (e.g., patient status, or report type),
document section types (e.g., current medications, past medical history, or discharge summary), named entities
and concepts (e.g., diagnoses, symptoms, or treatments) or semantic attributes (e.g., negation, severity, or
temporality).
From a clinical perspective, on the other hand, research studies are typically modelled and evaluated on a
patient- or population-level, such as predicting how a patient group might respond to specific treatments or
patient monitoring over time. While some NLP tasks consider predictions at the individual or group user level,
these tasks still constitute a minority. Owing to the discrepancy between scientific objectives of each field, and
because of differences in methodological evaluation priorities, there is no clear alignment between these eva-
luation approaches.
Here we provide a broad summary and outline of the challenging issues involved in defining appropriate
intrinsic and extrinsic evaluation methods for NLP research that is to be used for clinical outcomes research, and
vice versa. A particular focus is placed on mental health research, an area still relatively understudied by the
clinical NLP research community, but where NLP methods are of notable relevance. Recent advances in clinical
NLP method development have been significant, but we propose more emphasis needs to be placed on rigorous
evaluation for the field to advance further. To enable this, we provide actionable suggestions, including a
minimal protocol that could be used when reporting clinical NLP method development and its evaluation.
1. Introduction
Appropriate utilization of large data sources such as Electronic
Health Record (eHealth records or EHR) databases could have a dra-
matic impact on health care research and delivery. Owing to the large
amount of free text documentation now available in EHRs, there has
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been a concomitant increase in research to advance Natural Language
Processing (NLP) methods and applications for the clinical domain [1,2].
The field has matured considerably in recent years, addressing many of
the challenges identified by Chapman et al. [3], and meeting the re-
commendations by Friedman et al. [4].
For example, the above include recommendations to address the key
challenges of limited collaboration, lack of shared resources and eva-
luation-approaches of crucial tasks, such as de-identification, recogni-
tion and classification of medical concepts, semantic modifiers, and
temporal information. These challenges have been addressed by the
organization of several shared tasks. These include the Informatics for
Integrating Biology and the Bedside (i2b2) challenges [5–9], the Con-
ference and Labs of the Evaluation Forum (CLEF) eHealth challenges
[10–13], and the Semantic Evaluation (SemEval) challenges [14–16].
These efforts have enabled a valuable platform for international NLP
method development.
Furthermore, the development of open-source NLP software speci-
fically tailored to clinical text has led to increased adoptability. Such
NLP software include the clinical Text Analysis Knowledge Extraction
System (cTAKES)1 and Clinical Language Annotation, Modeling, and Pro-
cessing Toolkit (CLAMP),2 information extraction and retrieval infra-
structure solutions such as SemEHR [17], as well as general purpose
tools such as the the general architecture for text engineering (GATE)3 and
Stanford CoreNLP.4 New initiatives, such as the Health Natural Language
Processing (hNLP) Center,5 also aim to facilitate the sharing of re-
sources, which would enable further progress through availability,
transparency, and reproducibility of NLP methodologies.
In recent years, the field of mental health has shown a burgeoning
increase in the use of NLP strategies and methods, mainly because most
clinical documentation is in free-text, but also arising from the in-
creasing availability of other types of documents providing beha-
vioural, emotional, and cognitive indicators as well as cues on how
patients are coping with different conditions and treatments. Such texts
sources include social media and online fora [18–21] as well as doctor-
patient interactions [22–24] and online therapy [25], to mention a few
examples. However, although there have been a few shared tasks re-
lated to mental health [26–28] the field is still narrower than that of
biomedical or general clinical NLP.
The maturity of NLP method development and state-of-the-art re-
sults have led to an increase in successful deployments of NLP solutions
for complex clinical outcomes research. However, the methods used to
evaluate and appraise NLP approaches are somewhat different from
methods used in clinical research studies, although the latter often rely
on the former for data preparation and extraction. There is a need to
clarify these differences and to develop novel approaches and methods
to bridge this gap.
This paper stems from the findings of an international one-day
workshop in 2017 (see online Supplement). The objective was to ex-
plore these evaluation issues by outlining ongoing research efforts in
these fields, and brought together researchers and clinicians working in
the areas of NLP, informatics, mental health, and epidemiology. The
workshop highlighted the need to provide an overview of requirements,
opportunities, and challenges of using NLP in clinical outcomes re-
search (particularly in the context of mental health). Our aim is to
provide a broad outline of current state-of-the-art knowledge, and to
make recommendations on directions going forward in this field, with a
focus on considerations related to intrinsic and extrinsic evaluation is-
sues.
2. Evaluation paradigms
All empirical research studies need to be evaluated (or validated) in
order to allow for scientific assessment of a study. In clinical outcomes
research, studies are usually designed as clinical trials, cohort studies or
case-control studies, with the aim to assess whether a risk factor or
intervention has a significant association with an outcome of interest.
NLP method development, on the other hand, aims to produce com-
putational solutions to a given problem. Studies of diagnostic tools are
most similar to NLP method development - testing whether a history
item, examination finding or test result is associated with a subsequent
diagnosis. The most basic underlying construction for quantitative va-
lidation in both fields is a 2×2 contingency table (or confusion ma-
trix), where the number of correctly and incorrectly assigned values for
a given binary outcome or classification label is compared with a gold
(reference) standard, i.e. the set of ’true’ or correct values. This table
can then be used to calculate performance metrics such as precision
(Positive Predictive Value), recall (sensitivity), accuracy, F-score, and
specificity. In clinical studies, this can be used to calculate measures of
association, such as risk ratio and odds ratio. There are other evaluation
measures that can be used when the outcome is more complex, e.g.,
continuous or ranked (for NLP, see e.g., [29], for clinical prediction
models, see e.g., [30]).
Validation or evaluation of clinical outcomes whether it be a trial,
cohort or case-control study relies on statistical measurements of effect,
and can be validated internally (measured on the original study sample)
or externally (measured on a different sample) [31]. Typically, a
number of predictors (variables) interact in these models, thus multi-
variable models are common, where it is important to account for
biases to ensure model validity.
Because the goal of NLP method development is to produce com-
putational solutions to specific problems, evaluation criteria can be
intrinsic (evaluating an NLP system in terms of directly measuring its
performance on attaining its immediate objective) and extrinsic (eval-
uating an NLP system in terms of its usefulness in fulfilling an over-
arching goal where the NLP system is perhaps part of a more complex
process or pipeline) [32–34,29,35]. The goal of clinical research stu-
dies, on the other hand, typically relates to assessing the effect of a
treatment or intervention.
Clinical NLP method development has mainly focused on internal,
intrinsic evaluation metrics. Typically, these methods have been de-
veloped and evaluated on word, sentence or document level annota-
tions that model specific attributes and features, such as document
content (e.g., patient status, or report type), document section types
(e.g., current medications, past medical history, discharge or summary),
named entities and concepts (e.g., diagnoses, symptoms, or treatments),
or semantic attributes (e.g., negation, severity, or temporality).
Although the intrinsic evaluation metrics are important and valu-
able, especially when comparing different NLP methods for the same
task, they are not necessarily of value or particularly informative when
the task is applied on a higher-level problem (e.g., patient level) or on
new data. For instance, current state-of-the-art that is achieved in
medical concept classification is> 80% F-score [7], which is close to
human agreement on the same task; however, if such a system was to be
deployed in clinical practice, any> 0% error rate, such as the mis-
classification of a drug or a history of severe allergy, might be seen as
unacceptable.
True negatives are rarely taken into consideration in NLP evalua-
tion, often because this is intractable in text analysis [36]. Yet, speci-
ficity (the true negative ratio, i.e. the proportion of a gold standard
construct that is identified by the new assessment) is often a key factor
in clinical research, particularly in medical screening but also in cate-
gorisation of exposures (e.g. case status) and outcomes. Thus when
using outputs from NLP approaches in clinical research studies, it is not
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3. Opportunities and challenges from a clinical perspective
The opportunities and potential of NLP are hugely exciting for
health research generally, and for mental health research specifically.
As clinical informatics resources become larger and more comprehen-
sive as a result of text-derived meta-data, the possibility of determining
outcomes, prognoses, effectiveness, and harm are all within closer
reach, requiring fewer resources than would be needed to conduct
primary research studies. A variety of data sources are amenable to
clinical research such as social media, wearable device data, audio and
video recordings of team discussions and interactions. However, EHR-
derived data potentially offer the most immediate value, given the time
and patient numbers over which data have already been collected, their
comprehensive and now-established use across healthcare, and given
the depth of clinical information potentially available in real world
services. Compared to primary research cohorts, the coverage is huge
and substantially more generalisable, and allows for external validation
of models [37].
3.1. Clinical NLP applied on mental health records
A key issue with mental EHR data is that the most salient in-
formation for research and clinical practice tends to be entered in text
fields rather than pre-structured data, with up to 70% of the record
documented in free-text [38]. For instance, the Clinical Record Inter-
active Search (CRIS) system from the South London and Maudsley mental
health trust (SLaM) contained almost 30 million event notes and cor-
respondence letters, and more than 322, 000 patients,6 yielding an
average of 90 documents per patient (even more if additional text
content would be included, e.g., free-text entries in risk assessment
notes). This is partly because the most important features of mental
health care do not lend themselves to structured fields. Such features
include the salience of the self-reported experience (i.e. mental health
symptoms), determining treatment initiation and outcome evaluation,
as well as the complex circumstances influencing presentations and
prognoses (e.g., social support networks, recent or past stressful ex-
periences, psychoactive substance use). Moreover, written information
can be more accurate and reliable, and allows for expressiveness, which
better reflects the complexity of clinical practice [39,40]. While there
have been calls for increased structuring of health records, these seem
to be mainly driven by convenience issues for researchers or adminis-
trators (i.e. ease of access to pre-structured data) rather than the pre-
ferences of the clinical staff actually entering data [39].
Most clinical researchers and clinicians are accustomed to research
methods involving highly scrutinised de novo data collection with
standardised instruments (such as the Beck Depression Inventory (BDI) or
the Positive and Negative Syndrome Scale (PANNS)). These have estab-
lished psychometric properties for the concepts they measure, such as
symptom severity in patients with schizophrenia (e.g., positive symp-
toms such as delusions, hallucinations). Using NLP methods to derive
and identify such concepts from EHRs holds great promise, but requires
careful methodological design. If NLP algorithms are to be fit for pur-
pose, they need to demonstrate accurate and reliable measurement,
which in turn needs to be communicated in a language that is under-
standable across disciplines especially considering the differences in
language used by the clinical and NLP academic communities. Because
of the importance of information accuracy in medical practice, in-
cluding the validity and reliability of tests and instruments, translating
NLP system outputs to an interpretable measure is key. This way the
clinical community can easily understand the basis for the underlying
NLP model, allowing for the potential translation of NLP-derived ob-
servational findings into clinical interventions.
Moreover, ensuring that an NLP approach is appropriately designed
for a specific clinical problem is essential. For example, timely detection
of the risk of suicidal behaviour in patients using NLP approaches on
EHR data is clinically important, but challenging: not only because of
the various ways this can be documented in text, but also because of the
complexity of the clinical construct. Suicidal behaviour is relatively
rare, and current tools for assessing suicide risk are inadequate and
suffer from low PPV/precision [41]. Data-driven methods hold promise
as a solution to develop more accurate predictive models, but they need
to be carefully designed. In one case study,< 3% of EHR documents for
200 patients had any suicide-related information documented in free-
text, whilst at a patient level, 22% of the patients had at least one
document with written suicide-related information [42]. Thus, for this
type of use-case, it is important for method development to ensure an
appropriate sample (document or patient), and to provide interpretable
NLP output results.
Other key challenges in applying NLP on mental health records
include moving beyond simple named-entity recognition towards as-
certaining novel and more complex entities such as markers of socio-
economic status or life experiences, as well as unpicking temporality in
order to reconstruct disorder and treatment pathways. In addition,
there are the more computational challenges of moving beyond single-
site applications to wider multi-site provision of NLP resources, as well
as evaluating translation for international use. Other types of textual
data such as patient-generated text (e.g., online forums, questionnaires,
and feedback forms) involve additional challenges, e.g., the ability to
adapt models for clinical constructs such as mood recognition from a
wider population to individuals, as well as the ability to calculate mood
scores over time, based on a number of linguistic features and often in
the face of sparse or missing data.
3.2. Using NLP for large-sample clinical research
The capacity of NLP approaches to extract additional, non-struc-
tured information is particularly important for large-sample research
studies, which are often focused on identifying as many predictors (and
potential confounders) of an outcome as possible [43]. These may in-
clude factors at both the ‘macro-environment’, such as family/social
circumstances, and the individual patient-level, such as tobacco use
[44], and is especially important for mental health research given there
may be reticence to code stigmatised conditions, such as illicit drug use,
when they are not the primary reason for seeking treatment [45]. Also,
structured codes cannot accommodate diagnostic uncertainty, and do
not permit the recording of clinically-relevant information that supports
a diagnosis, e.g., sleep or mood, but is not the specific condition for
which a patient receives treatment [46]. Thus NLP approaches both
enable the improvement of case identification from health records
[46,47] and can provide a much richer set of data than could be
achieved by the use of structured data alone.
However, this increase in the depth of data provided by NLP can
come at a cost to study reproducibility and research transparency. An
EHR-based study requires a clear specification of how the data recorded
for each patient were collected and processed prior to analysis. In the
context of EHR research this is often referred to as developing ‘phe-
notypes’, with the intention that the algorithms developed can be re-
used by others [48–50]. Incorporation of NLP output data in phenotype
algorithms may make it more difficult for researchers using different
EHR data to replicate results. For instance, if the underlying data that
was used to develop an NLP solution to extract a phenotype such as
atrial fibrillation is specific to the EHR system, geographical area and
other factors, the NLP algorithm may produce different results if ap-
plied on new data for the same task.
Even if NLP methods are shared, their application may be hampered
if similar source documents are not available. This issue would be
compounded if multiple phenotypes are used to build the epidemiolo-
gical data set. One practical solution is to adopt some of the measures
suggested for clinically-focused observational research, such as the6 Counted on May 16th, 2018.
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publication of study protocols and/or cohort descriptions [51].
3.3. NLP in clinical practice — towards extrinsic evaluation
Nuances of human language mean that no NLP algorithm is com-
pletely accurate, even for a seemingly straightforward task such as
negation detection [52]. An error rate can be accommodated statisti-
cally in research, but to support decisions about individual patient care,
results of NLP must be verified by a clinician before being used to make
recommendations about patient management. Such verification might
be better accepted by the users if the system provides probabilistic
outputs rather than binary decisions. The difficulties in safely in-
corporating these uncertainties may have contributed to the gap be-
tween research applications of NLP and its use in clinical settings [2].
When algorithms are used in clinical decision support, it is important to
display the information that is used to make the recommendation, and
for clinicians to be aware of potential weaknesses of the algorithm.
Clinical decision systems are more useful if they provide re-
commendations within the clinical workflow at the time and location of
decision making [53].
Within EHR systems, NLP may be used to improve the user inter-
face, such as the ease of finding information in a patient’s record. Real-
time NLP can potentially assist clinicians to enter structured observa-
tions, evaluations or instructions from free text by, for example, auto-
matically transforming a paragraph into a diagnostic code or suggested
treatment. The accuracy of such algorithms may be tested by calcu-
lating the proportion of suggested structured entries that the clinician
verifies as being correct. Clinical NLP systems have not, as of yet, been
developed with clinical experts in mind, and have rarely been evaluated
according to extrinsic evaluation criteria. As NLP systems become more
mature, usability studies will also be a necessary step in NLP method
development, to ensure that clinicians’ and other non-NLP users’ input
can be taken into consideration. For instance, in the 2014 i2b2 Track 3 -
Software Usability Assessment, it was shown that current clinical NLP
software is hard to adopt [54]. Tools such as Turf (EHR Usability
Toolkit)7could be made common practice when developing NLP solu-
tions for clinical research problems. NLP could also become more in-
tegrated into EHR systems in the future, where evaluation metrics that
focus on the time a documentation task takes, documentation quality,
and other aspects also need to be considered [55].The ideal evaluation
would be a randomized trial in clinical practice, comparing usability
and data quality between user interfaces incorporating different NLP
algorithms.
4. Opportunities and challenges from a Natural Language
Processing perspective
The two major approaches to NLP, as described by Friedman et al.
[4], namely symbolic (based on linguistic structure and world knowl-
edge) and statistical methods (based on frequency of occurrence and
distribution patterns) methods, are still dominant in clinical NLP de-
velopment. Advances in machine learning algorithms, such as neural
networks, have influenced NLP applications, and there are, of course,
further developments to be expected. However, many of the develop-
ments, particularly in neural network models, assume large, labeled
datasets, and these are not readily available for clinical use-cases that
require analysis of EHR text content. Another challenge is data avail-
ability — ethical regulations and privacy concerns need to be addressed
if authentic EHR data are to be used for research, but there are also
alternative methods that can be used to create novel resources (Section
4.1).
Furthermore, evaluation of NLP systems is still typically performed
with standard statistical metrics based on intrinsic criteria, not
necessarily optimal for the clinical research problem at hand. To ad-
dress such issues, it is important to identify which level of analysis is
appropriate, and model the problem accordingly (Section 4.2). En-
riching informatics approaches with novel data sources, using evalua-
tion metrics that capture novel aspects such as model interpretability or
time sensitivity, and developing NLP solutions with the clinical end-
users in mind (Section 4.3) could lead to considerable advances in this
field.
4.1. Methods for developing shareable data
Risks for compromised privacy are particularly evident in analyzing
text from health records (i.e. the inability to fully convince the relevant
authorities that all explicit and implicit privacy-sensitive information
has been de-identified) and in big data health research more generally
(i.e. unforeseen possibilities of inferring an individual’s identity after
record linkages from multiple de-identified sources). The same ethical
and legal policies that protect privacy complicate the data storage, use,
and exchange from one study to another, and the constraints for these
data exchanges differ between jurisdictions and countries [56].
As a timely solution to these data exchange problems, synthetic
clinical data has been developed. For example, a set of 301 patient cases
which includes recorded spoken handover and annotated verbatim
transcriptions based on synthetic patient profiles, has been released and
used in shared tasks in 2015 and 2016 [12,13,57]. Similarly, synthetic
clinical documents have been used in 2013 and 2014 in shared tasks on
clinical NLP in Japanese [58]. Synthetic data has been successful in
tasks such as dialogue generation [59] and is a promising direction at
least as a complement for method development where access to data is
challenging.
4.2. Intrinsic evaluation and representation levels
When considering the combination of NLP methods and clinical
outcomes research, differences in granularity are a challenge. NLP
methods are usually developed to identify and classify instances of
some clinically relevant phenomenon at a sub-document or document
level. For example, NLP methods for the extraction of a patient’s
smoking status (e.g., current smoker, past smoker or non-smoker) will
typically consider individual phrases that discuss smoking, of which
there may be several in a single document [60]. Even in cases where an
NLP method is used to classify a whole document (e.g., assigning tumor
classifications to whole histopathology reports [61]), there may be
several documents for an individual patient.
Typically, in evaluating clinical NLP methods, a gold standard
corpus with instance annotations is developed, and used to measure
whether or not an NLP approach correctly identifies and classifies these
instances. If a gold standard corpus contains multiple annotations and
documents for one patient, and the NLP system correctly classifies
these, the evaluation score will be higher. For clinical research, on the
other hand, only one of these instances may be relevant and correct. In
the extreme, a small number of patients with a high number of irrele-
vant instances, could bias the NLP evaluation relative to the clinical
research question. For instance, a gold standard corpus annotated on a
mention level for positive suicide-related information (patient is sui-
cidal) or negated (patient denies suicidal thoughts) was used to develop an
NLP system [62] which had an overall accuracy of 91.9%. However,
when this system was applied for a clinical research project to identify
suicidal patients, implementing a document- and, more crucially, a
patient-level classification based on such instance-level annotations
required non-trivial assumptions, because the documents could contain
several positive and negative mentions, and each patient could have
several EHR documents [42].
There is thus often a gap between instance level and patient level
evaluations. In order to resolve the differences in granularity between
the NLP and clinical outcomes evaluations, this gap needs to be bridged7 https://sbmi.uth.edu/nccd/turf/.
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somehow. Typically, some post-processing will be required, in order to
filter the instances found by the NLP method, before their use in clinical
outcomes research. For example, post-processing might merge in-
stances, or might remove those that are irrelevant. For some use-cases,
this post-processing procedure can be based on currently available
evidence, such as case identification for certain diseases (e.g., asthma
status [63]).
The gap as described does not always exist, and post-processing is
not always appropriate. There are cases in which an NLP method might
be used to process all of the relevant text associated with a single pa-
tient, over time, in order to directly predict a single outcome; for ex-
ample, all past text (and other information) could be used in order to
assign a diagnosis code [64]. Moreover, for some clinical use-cases,
patient-level annotations by e.g., manual chart review of sets of notes
for one patient-level clinical label might in some cases be more efficient
for developing gold standards and subsequent NLP solutions. Evalua-
tion metrics for such use-cases could be developed to measure the de-
gree that the NLP system correctly classifies groups compared to
manual review. For specific use-cases, this approach might even be
more appropriate than focusing on mention- and document-level an-
notations. Looking further, NLP methodology that addresses clinical
objectives by not only finding relevant instances, but actually sum-
marising all relevant information over time, is desirable; however, this
is a non-trivial aspiration, particularly considering methods for eva-
luation and conveyance of such summaries.
4.3. Beyond electronic health record data
Work on using computational language analysis on speech tran-
scripts to study communication disturbances in patients with schizo-
phrenia [65] or to predict onset of psychosis [66,67] has shown pro-
mising results. Further, the availability of large datasets has led to
advances in the field of psycholinguistics [68].
The increasing availability online of patient related texts including
social media posts and themed fora, especially around long term con-
ditions, have also lead to an increase in NLP applications for mental
health and the health domain in general. For example, recent NLP work
classifies users into patient groups based on social media posts over
time [21,69,70], prioritises posts for potential interventions based on
topics, sentiment and the overall conversation thread [27] or identifies
temporal expressions and relations within clinical texts [15,16].
Whilst this is encouraging in terms of the interaction between NLP
and the health domain, these tasks are still primarily evaluated using
classic NLP system performance metrics such as accuracy, recall, and F-
score. Recent NLP community efforts have initiated new evaluation
levels and metrics, e.g., prediction of current and future psychological
health based on childhood essays from longitudinal cohort data as in
the 2018 Computational Linguistics and Clinical Psychology Workshop
(CLPsych) shared task,8 however the direct clinical applicability of such
approaches is yet to be shown. Work by Tsakalidis et al. [71] is the first
to use both language and heterogeneous mobile phone data to predict
mental well-being scores of individual users over time calibrated
against psychological scales. Results were promising, yet their evalua-
tion strategy involved training and testing of data from all users, a
scenario often encountered in studies involving mood score predictions
using mobile phone data [72–74]. However, a more realistic evaluation
scenario would involve either: (a) intra-user predictions over time, that
is, for the same user calculating a mood score or other health indicator
given previous data in a sequence, at consecutive time intervals or (b)
predictions of some indicator, over time, for an unseen user, given a
model created on the basis of other users [75].
For these tasks to have potential clinical utility, new evaluation
metrics would need to be introduced that focus on a number of other
aspects, such as:
• time sensitive and timely prediction: longitudinal prediction of an in-
dicator such as a score from a psychological scale or other health
indicator. These would need to be predicted over time as monitoring
points rather than predictions that are independent of time, as is the
case of current standard classification approaches.• personalised models: intra-user models are very useful for persona-
lised health monitoring. However, such personalised models would
require large amounts of longitudinal data for individual users
which are not often available.• model interpretability: a model should provide confidence scores for
its predictions and provide evidence for the prediction. Current
model evaluation focusses on performance without any regard to
interpretability.
5. Actionable guidance and directions for the future
NLP method development for the clinical domain has reached ma-
ture stages and has become an important part of advancing data-driven
health care research. In parallel, the clinical community is increasingly
seeing the value and necessity of incorporating NLP in clinical out-
comes studies, particularly in domains such as mental health, where
narrative data holds key information. However, for clinical NLP method
development to advance further globally and, for example, become an
integral part of clinical outcomes research, or have a natural place in
clinical practice, there are still challenges ahead. Based on the discus-
sions during the workshop, the main challenges include data avail-
ability, evaluation workbenches and reporting standards. We summarize
these below and provide actionable suggestions to enable progress in
this area.
5.1. Data availability
The lack of sufficiently large sets of shareable data is still a problem
in the clinical NLP domain. We encourage the increased development of
alternative data sources such as synthetic clinical notes [57,58], which
alleviates the complexities involved in governance structures. However,
in parallel, initiatives to make authentic data available to the research
community through alternative governance models are also en-
couraged, like the MIMIC-III database [76]. Greater connection be-
tween NLP researchers, primary data collectors, and study participants
are required. Further studies in alternative patient consent models (e.g.,
interactive e-consent [77]) could lead to larger availability of real-
world data, which in turn could lead to substantial advances in NLP
development and evaluation. Moving beyond EHR data, there is valu-
able information also in accessible online data sources such as social
media (e.g., PatientsLikeMe), that are of particular relevance to the
mental health domain, and that could also be combined with EHR data
[78]. Efforts to engage users in donating their public social media and
sensor data for research such as OurDataHelps9 are interesting avenues
that could prove very valuable for NLP method development. Further-
more, in addition to written documentation, there is promise in the use
of speech technologies, specifically for information entry at the bedside
[57,79–83].
5.2. Evaluation workbenches
Current clinical NLP methods are typically developed for specific
use-cases and evaluated intrinsically on limited datasets. Using such
methods off-the-shelf on new use-cases and datasets leads to unknown
8 http://clpsych.org/shared-task-2018/. 9 https://ourdatahelps.org/.
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performance. For clinical NLP method development to become more
integral in clinical outcomes research, there is a need to develop eva-
luation workbenches that can be used by clinicians to better understand
the underlying parts of an NLP system and its impact on outcomes.
Work in the general NLP domain could be inspirational for such de-
velopment, for instance integrating methods to analyse the effect of
NLP pipeline steps in downstream tasks (extrinsic evaluation) such as
the effect of dependency parsing approaches [84]. Alternatively,
methods that enable analysis of areas where an existing NLP solution
might need calibration when applied on a new problem, e.g., by pos-
terior calibration [85] are an interesting avenue of progress. If clinical
NLP systems are developed for non-NLP experts, to be used in sub-
sequent clinical outcomes research, the NLP systems need to be easy to
use. Facilitating the integration of domain knowledge in NLP system
development can be done by providing support for formalized knowl-
edge representations that can be used in subsequent NLP method de-
velopment [86].
5.3. Reporting standards
Most importantly, ensuring transparency and reproducibility of
clinical NLP methods is key to advance the field. In the clinical research
community, the issue of lack of scientific evidence for a majority of
reported clinical studies has been raised [87]. Several aspects need to
be addressed to make published research findings scientifically valid,
among others replication culture and reproducibility practices [88].
This is true also for clinical NLP method development. We propose a
minimal protocol inspired by [32], see Figs. 1 and 2, that outlines the
key details of any clinical NLP study; by reporting on these, others can
easily identify whether or not a published approach could be applicable
and useful in a new study and for example, whether or not adaptations
might be necessary. This could encourage further development of a
comprehensive guidance framework for NLP, similar to what has been
proposed for the reporting of observational studies in epidemiology in
the STROBE statement [89], and other initiatives (e.g., [90,91,51]).
Fig. 1. Example of a suggested structured protocol with essential details for documenting NLP approaches and performed evaluations. The example includes different
levels of evaluation (intrinsic and extrinsic) that could be outlined with details about the task, metrics, results, and error analysis/comments.
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The key details that are needed are:
• Data: What type of source data was used? How was it sampled?
What is the size (in terms of sentences, words) How was the data
obtained? Is it available to other researchers?• NLP approach: What was the objective or task? At which type of
textual unit is analysis performed (document, sentence, entities,
word)? Is there a gold/reference standard? If so, how was the gold/
reference standard generated? If it was manual, what was the Inter-
rater/annotator agreement? Have the guidelines and definitions
been made publicly available?• Model development: what type of approach was taken? Parameter
settings? Prerequisites?• Evaluation: was the model evaluated intrinsically or extrinsically?
Which metrics were used? What types of errors were common? If the
evaluation was extrinsic, what assumptions were made? For ex-
ample, if an NLP output provides counts of mentions for a condition,
what threshold for determining whether or not someone can be
considered a case was chosen, and why? How was the conversion
from mention to case level done? Conversely, if an NLP system
provides an output for a patient-level label based on a set of in-
formation sources (e.g., documents), what method was applied to
identify and analyse disagreements?
6. Conclusions
We have sought to provide a broad outline of the current state-of-
the-art, opportunities, challenges, and needs in the use of NLP for
health outcomes research, with a particular focus on evaluation
methods. We have outlined methodological aspects from a clinical as
well as an NLP perspective and identify three main challenges: data
availability, evaluation workbenches and reporting standards. Based on
these, we provide actionable guidance for each identified challenge. We
propose a minimal structured protocol that could be used when re-
porting clinical NLP method development and its evaluation, to enable
transparency and reproducibility. We envision further advances parti-
cularly in methods for data access, evaluation methods that move be-
yond current intrinsic metrics and move closer to clinical practice and
utility, and in transparent and reproducible method development.
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